Asset

CAVROTOLIMOD

Exicure Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (1)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT03086278phase1completed2017-10-202018-08-16Exicure, Inc.A Study of AST-008 in Healthy Subjects

FDA applications (0)

This company has no applications containing this asset.

Marketed products (0)